Ani Pharmaceuticals (ANIP) Operating Income Growth (1y) (2013 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Operating Income Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -150.77% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -97.30% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -80.43% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 16.52% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 66.67% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 191.25% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | -5.82% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 163.58% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 191.25% |
| Mar 31, 2026 | 48.46% |
| Dec 31, 2025 | 894.13% |
| Sep 30, 2025 | 276.62% |
| Jun 30, 2025 | 168.76% |
| Mar 31, 2025 | 28.96% |
| Dec 31, 2024 | -165.09% |
| Sep 30, 2024 | -214.32% |
| Jun 30, 2024 | -58.32% |
| Mar 31, 2024 | 105.28% |
| Dec 31, 2023 | 269.56% |
| Sep 30, 2023 | 459.32% |
| Jun 30, 2023 | 196.04% |
| Mar 31, 2023 | 151.55% |
| Dec 31, 2022 | 107.67% |
| Sep 30, 2022 | -40.23% |
| Jun 30, 2022 | 16.97% |
| Mar 31, 2022 | -730.38% |
| Dec 31, 2021 | -7,267.07% |
| Sep 30, 2021 | -227.12% |